Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Maria Maddalena Squillante"'
HDV RNA Levels and Progression of Hepatitis Delta Infection: A 14 Year Follow Up Experience in Italy
Autor:
Alessandra Mangia, Maria Maddalena Squillante, Filippo Fraticelli, Maria Chiara Cavorsi, Giulia Paroni, Lucia Zaffarano, Annarita Valeria Piazzolla
Publikováno v:
Cells, Vol 12, Iss 10, p 1413 (2023)
Background: Identification of outcome predictors is one of the unmet needs in chronic HDV infection. Until recently, no reliable quantitative assays for HDV RNA were available. Aims: To evaluate the impact of baseline viremia on natural history of HD
Externí odkaz:
https://doaj.org/article/5066e36e0b094067b7eedd55176551ae
Autor:
Vincenzo Giambra, Annarita Valeria Piazzolla, Giovanna Cocomazzi, Maria Maddalena Squillante, Elisabetta De Santis, Beatrice Totti, Chiara Cavorsi, Francesco Giuliani, Nicola Serra, Alessandra Mangia
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1281 (2022)
Background: LC has been associated with hyporesponsiveness to several vaccines. Nonetheless, no data on complete serological and B- and T-cell immune response are currently available. Aims: To assess, in comparison with healthy controls of the same a
Externí odkaz:
https://doaj.org/article/54827aff182a402fa9df69500f28593c
Autor:
Giovanna Cocomazzi, Valeria Piazzolla, Maria Maddalena Squillante, Stefano Antinucci, Vincenzo Giambra, Francesco Giuliani, Alberto Maiorana, Nicola Serra, Alessandra Mangia
Publikováno v:
Vaccines, Vol 9, Iss 8, p 913 (2021)
Purpose: Clinical significance and durability of serological response after mRNA COVID-19 vaccines is under investigation. Data on early virological response are limited. To iden-tify potential predictors of antibody durability, circulating antibody
Externí odkaz:
https://doaj.org/article/e5851376729f4d6388f52dd3b7d38b8c
Autor:
Annarita Valeria Piazzolla, Giulia Paroni, Francesca Bazzocchi, Mauro Cassese, Antonio Cisternino, Luigi Ciuffreda, Franco Gorgoglione, Leonardo Gorgoglione, Vincenzo Palazzo, Natale Sciannamè, Marco Taurchini, Pasquale Vaira, Giovanna Cocomazzi, Maria Maddalena Squillante, Filippo Aucella, Nicola Cascavilla, Salvatore De Cosmo, Michelantonio Fania, Antonio Greco, Antonio Laborante, Maurizio Leone, Evaristo Maiello, Mauro Salvatori, Lazzaro Di Mauro, Alessandra Mangia
Publikováno v:
Pathogens, Vol 10, Iss 6, p 695 (2021)
Background and Aims: The WHO has solicited all countries to eliminate HCV by 2030. The Italian government started routine screening for HCV infection in January 2021, initially targeting subjects born between 1969 and 1989. With the aim of achieving
Externí odkaz:
https://doaj.org/article/858d037664be4c7f85cf1c6dc56a0b55
Autor:
Alessandra Mangia, Giovanni Cenderello, Massimiliano Copetti, Gabriella Verucchi, Valeria Piazzolla, Celeste Lorusso, Rosanna Santoro, Maria Maddalena Squillante, Alessandra Orlandini, Rosalba Minisini, Alessia Ciancio
Publikováno v:
Cells, Vol 8, Iss 4, p 313 (2019)
In clinical trials, a sofosbuvir/velpatasvir (SOF/VEL) pangenotypic single-tablet regimen was associated with high sustained virological response (SVR) rates at 12 weeks (SVR12) after the end of treatment, regardless of genotype and fibrosis stage. N
Externí odkaz:
https://doaj.org/article/28005e984362490485c528fccc3409f7
Autor:
Alessandra Mangia, Annarita Valeria Piazzolla, Maria Maddalena Squillante, Giovanna Cocomazzi, Vanna Maria Valori, Massimiliano Copetti, Paola Parente, Vito Attino, Maria Guido
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 19; Pages: 5969
Background and aim: Non-alcoholic fatty liver disease (NAFLD) may progress to severe liver fibrosis and cirrhosis. A limited number of studies with a long follow up assessed fibrosis progression and related predictors in untreated patients with a his
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b826d8200edf1da98fd3cc4cf821086
https://pubmed.ncbi.nlm.nih.gov/36233834
https://pubmed.ncbi.nlm.nih.gov/36233834
Autor:
Giovanna Cocomazzi, Valeria Piazzolla, Rosa Cotugno, Maria Maddalena Squillante, Alessandra Mangia
Publikováno v:
World Journal of Gastroenterology
Hepatitis C virus (HCV) elimination by 2030, using direct-acting antiviral treatments, has been promoted by the World Health Organization. This achievement is not attainable, however, particularly after the 2020 pandemic of the coronavirus disease 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9d8bc44f00d0889b683ca2ed38dbd3
https://doi.org/10.3748/wjg.v27.i16.1728
https://doi.org/10.3748/wjg.v27.i16.1728
Autor:
Massimiliano Copetti, Giovanni Cenderello, Maria Maddalena Squillante, Alessia Ciancio, Alessandra Mangia, Andrea Fontana, Nicola Minerva, Gabriella Verucchi, Valeria Piazzolla
Publikováno v:
World Journal of Clinical Cases
Liver injury has been reported in coronavirus disease 2019 (COVID-19) cases but the impact of pre-existing liver damage and related etiology have not been completely elucidated. Our research interests include the potential reciprocal influence of COV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e75d6bfacdaa01f1f8fe5eb33ce8e5
https://doi.org/10.12998/wjcc.v8.i22.5831
https://doi.org/10.12998/wjcc.v8.i22.5831
Autor:
M. Cassese, Alessandra Mangia, Marco Taurchini, M. Fania, Nicola Cascavilla, P. Vaira, Maria Maddalena Squillante, L. Gorgoglione, N. Sciannamè, Evaristo Maiello, A. Cisternino, V. Palazzo, Giovanna Cocomazzi, A. Laborante, Filippo Aucella, Maurizio Leone, F. Gorgoglione, L. Di Mauro, M P Salvatori, S. De Cosmo, Giulia Paroni, Francesca Bazzocchi, L. Ciuffreda, Antonio Greco, A. V. Piazzolla
Publikováno v:
Pathogens
Volume 10
Issue 6
Pathogens, Vol 10, Iss 695, p 695 (2021)
Volume 10
Issue 6
Pathogens, Vol 10, Iss 695, p 695 (2021)
Background and Aims: The WHO has solicited all countries to eliminate HCV by 2030. The Italian government started routine screening for HCV infection in January 2021, initially targeting subjects born between 1969 and 1989. With the aim of achieving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e01c81879021ea18de113d670613e5b
Autor:
Maria Franca Rina, Giovanna Cocomazzi, Maria Maddalena Squillante, Nazario Augello, Alessandra Mangia, Ernesto Agostinacchio, Fausto Campanozzi, Camilla Iannuzziello, Egidio Visaggi, Antonio Canosa, Mattia Falcone, Angelo De Giorgi, Valeria Piazzolla
Publikováno v:
United European Gastroenterol J
Background Rates of Hepatitis C virus (HCV) testing and diagnosis are variable among people who use drugs (PWUD). In Puglia in 2018, of 871 subjects screened, 38% had HCV antibodies (HCVAb). Despite sustained virologic response at week 12 Sustained v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25576edf0ab3cc986a6669a3fb6ac16c
https://pubmed.ncbi.nlm.nih.gov/34687156
https://pubmed.ncbi.nlm.nih.gov/34687156